Online first
Short communication
Published online: 2024-06-03
Levosimendan in critical aortic stenosis complicated by cardiogenic shock: Case reports and review of literature
Pubmed: 38845426
Abstract
Not available
References
- Varadarajan P, Kapoor N, Bansal RC, et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg. 2006; 82(6): 2111–2115.
- Tribouilloy C, Lévy F, Rusinaru D, et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol. 2009; 53(20): 1865–1873.
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention. 2022; 17(14): e1126–e1196.
- Khot UN, Novaro GM, Popović ZB, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med. 2003; 348(18): 1756–1763.
- Pathak A, Lebrin M, Vaccaro A, et al. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects. Journal of Clinical Pharmacy and Therapeutics. 2013; 38(5): 341–349.
- Fang M, Cao H, Wang Z. Levosimendan in patients with cardiogenic shock complicating myocardial infarction: A meta-analysis. Med Intensiva (Engl Ed). 2018; 42(7): 409–415.
- Masha L, Vemulapalli S, Manandhar P, et al. Demographics, procedural characteristics, and clinical outcomes when cardiogenic shock precedes TAVR in the united states. JACC Cardiovasc Interv. 2020; 13(11): 1314–1325.
- Debry N, Kone P, Vincent F, et al. Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters. EuroIntervention. 2018; 14(5): e519–e525.
- Goel K, Shah P, Jones BM, et al. Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock. Eur Heart J. 2023; 44(33): 3181–3195.
- Prior DL, Flaim BD, MacIsaac AI, et al. Pre-operative use of levosimendan in two patients with severe aortic stenosis and left ventricular dysfunction. Heart Lung Circ. 2006; 15(1): 56–58.
- Hoefer D, Jonetzko P, Hoermann C, et al. Successful administration of levosimendan in a patient with low-gradient low-output aortic stenosis. Wien Klin Wochenschr. 2006; 118(1-2): 60–62.
- Järvelä K, Maaranen P, Sisto T, et al. Levosimendan in aortic valve surgery: cardiac performance and recovery. Journal of Cardiothoracic and Vascular Anesthesia. 2008; 22(5): 693–698.
- Caetano F, Mota P, Barra S, et al. Use of levosimendan in critically ill patients with severe aortic stenosis and left ventricular dysfunction. Eur Heart J Acute Cardiovasc Care. 2012; 1(4): 281–284.
- García-González MJ, Jorge-Pérez P, Jiménez-Sosa A, et al. Levosimendan Improves Hemody-namic Status in Critically Ill Patients with Severe Aortic Stenosis and Left Ventricular Dysfunction: An Interventional Study. Cardiovascular Therapeutics. 2015; 33(4): 193–199.
